Hefei Lifeon Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hefei Cubic Pharmaceutical Co., Ltd. was founded in 2002 and is an innovative pharmaceutical enterprise that integrates the research and development, production, and sales of pharmaceutical preparations and raw materials, as well as the wholesale and retail of drugs and medical devices. It covers the entire industrial chain of the pharmaceutical industry and pharmaceutical commerce, and its main industrial products include cardiovascular drugs, digestive system drugs, skin topical drugs, endocrine system drugs, and other fields. Cubic Pharmaceutical has 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 pharmaceutical retail chain enterprise, and was successfully listed on the SME board of the Shenzhen Stock Exchange on December 15, 2020. The company has obtained more than 30 invention patents, and has successively obtained honors such as "Key High tech Enterprise of the National Torch Plan", "Anhui Innovative Enterprise", "Provincial Recognized Enterprise Technology Center", "Most Valuable Enterprise in China's Pharmaceutical Industry", "Anhui Specialized, Refined, and New Small and Medium sized Enterprise", "Anhui Drug Sustained Release Engineering Technology Center", and "Hefei Intellectual Property Demonstration Enterprise"; From 2013 to 2020, we have been awarded the honor of "Top 100 Comprehensive Strength Industrial Enterprises in China's Chemical and Pharmaceutical Industry"; The industrial and commercial enterprises of the company are both winners of the "Anhui Province Pharmaceutical Quality Award" and "Double Excellence Award", Anhui Province A-level tax paying enterprises, and Anhui Province's contract abiding and trustworthy units; The company has a postdoctoral research workstation in Anhui Province, which is a legal entity of the Anhui Pharmaceutical Industry Association and a vice president unit of the China Chemical Pharmaceutical Industry Association. Cubic Pharmaceuticals adheres to the concept of "innovation is the highest efficiency of the enterprise", establishes an osmotic pump controlled release technology platform composed of four major parts: formula technology, formulation evaluation technology, formulation engineering technology, and key equipment technology, and continuously improves the development and industrialization capabilities of osmotic pump formulation products. Its main products include felodipine sustained-release tablets (II), doxazosin mesylate sustained-release tablets, and so on. The company's "Research and Development and Industrialization Application of Monolayer Core Osmotic Pump Controlled Release Technology for Insoluble Drugs" project has won the first prize of the Anhui Provincial Science and Technology Award. After decades of careful construction, the company has established a professional, innovative, and shared values excellent management team and professional practitioners in their respective fields, laying a solid foundation for the stable operation of the company and also serving as the backbone for its continuous development and growth. The company has initiated a talent strategy of "introduction, cultivation, and cooperation". According to the company's development strategy, we need to introduce high-end technical talents from both domestic and international sources to serve as leaders in various research and development disciplines; Adopting mentoring and gradient training models, conducting talent cultivation in the process of research and practice, improving incentive and innovation policies, and establishing channels for the growth and development of R&D personnel; Establish long-term and stable cooperative relationships with experts in the field of demand through various means such as external recruitment, directly participate in and guide the research and development of our company, and effectively utilize external talent resources. Cubic Pharmaceuticals adheres to the business philosophy of "being honest and specialized", actively advocates a corporate culture of "handling affairs according to regulations and procedures", and pursues institutionalized management centered on efficiency. Cubic Pharmaceuticals will leverage the wisdom of all its employees, innovate pragmatically, accelerate development, and cooperate sincerely with suppliers, distributors, hospitals, and retail terminals with excellent products and services. Together, we will create a community of interests and write a more brilliant new chapter for Cubic Pharmaceuticals, making greater contributions to the cause of human health. |
| Headquarter | Hefei |
| Establish Date | 7/16/2002 |
| Listed Code | 003020.SZ |
| Listed Date | 12/15/2020 |
| Chairman | Ji Junqiu. |
| CEO | Cui Huanxi. |
| Website | www.lifeon.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
